Published in J Clin Endocrinol Metab on February 01, 1991
Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism. J Clin Invest (2012) 2.38
Glucocorticoids suppress bone formation via the osteoclast. J Clin Invest (2006) 1.92
Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice. Ann Rheum Dis (2002) 1.80
Beclomethasone inhalation decreases serum osteocalcin concentrations. BMJ (1991) 1.50
Systemic effects of high dose inhaled steroids: comparison of beclomethasone dipropionate and budesonide in healthy subjects. Thorax (1993) 1.18
Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club. Osteoporos Int (2005) 0.99
Should bisphosphonates be used for long-term treatment of glucocorticoid-induced osteoporosis? Arthritis Rheum (2011) 0.95
Reverse effect of mammalian hypocalcemic cortisol in fish: cortisol stimulates Ca2+ uptake via glucocorticoid receptor-mediated vitamin D3 metabolism. PLoS One (2011) 0.92
Drug-vitamin D interactions: a systematic review of the literature. Nutr Clin Pract (2013) 0.92
BMP-2 vs. BMP-4 expression and activity in glucocorticoid-arrested MC3T3-E1 osteoblasts: Smad signaling, not alkaline phosphatase activity, predicts rescue of mineralization. Growth Factors (2008) 0.89
Urinary excretion of the pyridinium cross-links of collagen in systemic lupus erythematosus. Clin Rheumatol (1998) 0.82
Biochemical bone markers in nephrotic children. Pediatr Nephrol (2004) 0.80
Effect of sodium fluoride on the prevention of corticosteroid-induced osteoporosis. Osteoporos Int (1997) 0.79
Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies. Osteoporos Int (2015) 0.79
Safety and pharmacodynamic dose response of short-term prednisone in healthy adult subjects: a dose ranging, randomized, placebo-controlled, crossover study. BMC Musculoskelet Disord (2016) 0.78
Glycyrrhizic acid (GCA) as 11β-hydroxysteroid dehydrogenase inhibitor exerts protective effect against glucocorticoid-induced osteoporosis. J Bone Miner Metab (2012) 0.77
Short-term effects of glucocorticoid therapy on biochemical markers of bone metabolism in Japanese patients: a prospective study. J Bone Miner Metab (2008) 0.76
Urinary deoxypyridinoline is a BMD-independent marker for prevalent vertebral fractures in postmenopausal women treated with glucocorticoid. Osteoporos Int (2009) 0.76
Endogenous Glucocorticoids and Bone. Bone Res (2013) 0.76
The effects of piper sarmentosum water extract on the expression and activity of 11β-hydroxysteroid dehydrogenase type 1 in the bones with excessive glucocorticoids. Iran J Med Sci (2012) 0.75
Site-Specific Variations in Bone Mineral Density under Systemic Conditions Inducing Osteoporosis in Minipigs. Front Physiol (2017) 0.75
Short-term glucocorticoid treatment causes spinal osteoporosis in ovariectomized rats. Eur Spine J (2014) 0.75
Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int (2009) 5.43
Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol (Oxf) (1999) 3.99
On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. Qual Life Res (2003) 3.71
Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol (Oxf) (1997) 3.44
Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol (1989) 3.02
Falls in the elderly: a prospective study of risk factors and risk profiles. Am J Epidemiol (1996) 2.91
Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med (1990) 2.82
IOF position statement: vitamin D recommendations for older adults. Osteoporos Int (2010) 2.79
Fall-risk screening test: a prospective study on predictors for falls in community-dwelling elderly. J Clin Epidemiol (2001) 2.69
Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporos Int (2007) 2.56
Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res (2000) 2.55
Impact of nutrition on muscle mass, strength, and performance in older adults. Osteoporos Int (2012) 2.48
Smoking and risk of Graves' disease. JAMA (1993) 2.35
Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial. Clin Endocrinol (Oxf) (2005) 2.34
Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet (1993) 2.20
Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy. N Engl J Med (1989) 2.13
[Bone density measurement and prevention of fractures: who should be eligible?]. Ned Tijdschr Geneeskd (1996) 2.04
Skeletal muscle mass and muscle strength in relation to lower-extremity performance in older men and women. J Am Geriatr Soc (2000) 1.99
Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. Arch Intern Med (1990) 1.95
Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin Immunol (2001) 1.94
Predictors for falls and fractures in the Longitudinal Aging Study Amsterdam. J Bone Miner Res (1998) 1.86
Mean wall thickness of trabecular bone packets in the human iliac crest: changes with age. Calcif Tissue Res (1978) 1.83
Value of myoglobin, troponin T, and CK-MBmass in ruling out an acute myocardial infarction in the emergency room. Circulation (1995) 1.82
Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways. AIDS (2001) 1.81
Weight-bearing activity during youth is a more important factor for peak bone mass than calcium intake. J Bone Miner Res (1994) 1.81
Demonstration of the prostatic origin of metastases: an immunohistochemical method for formalin-fixed embedded tissue. Cancer (1978) 1.71
Health-related quality of life and radiographic vertebral fracture. Osteoporos Int (2003) 1.70
Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab (1995) 1.69
Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. Eur J Endocrinol (2009) 1.68
A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. J Clin Endocrinol Metab (2001) 1.68
Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men. Metabolism (1991) 1.68
Consequences of vertebral deformities in older men and women. J Bone Miner Res (2000) 1.67
A risk profile for identifying community-dwelling elderly with a high risk of recurrent falling: results of a 3-year prospective study. Osteoporos Int (2006) 1.67
Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy. J Clin Endocrinol Metab (1995) 1.62
Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clin Endocrinol (Oxf) (2000) 1.61
Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun (1994) 1.57
Management of the nontoxic multinodular goitre: a European questionnaire study. Clin Endocrinol (Oxf) (2000) 1.55
Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial. Osteoporos Int (2006) 1.55
The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer (1999) 1.53
The clinical value of lactate dehydrogenase in serum: a quantitative review. Eur J Clin Chem Clin Biochem (1997) 1.53
Prediction of post partum thyroid dysfunction: can it be improved? Eur J Endocrinol (1998) 1.50
Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost (1996) 1.47
Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol (1995) 1.46
Towards implementation of optimum nutrition and better clinical nutrition support. Clin Nutr (2001) 1.45
The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasty. Eur Heart J (2002) 1.45
One-hour test for estimating intestinal absorption of calcium by using stable strontium as a marker. Clin Chem (1994) 1.44
Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med (2007) 1.44
Evaluation of Endocrine Tests. C: glucagon and clonidine test in phaeochromocytoma. Neth J Med (2009) 1.43
Whole-body resting and exercise-induced lipolysis in sarcopenic [corrected] patients with COPD. Eur Respir J (2008) 1.43
Ruling out acute myocardial infarction early with two serial creatine kinase-MBmass determinations. Eur Heart J (1999) 1.43
Vitamin D status among patients with hip fracture and elderly control subjects in Yekaterinburg, Russia. Osteoporos Int (2005) 1.42
Infusion of long-chain or medium-chain triglycerides inhibits peripheral glucose metabolism in men. JPEN J Parenter Enteral Nutr (1995) 1.42
Static and dynamic measures of frailty predicted decline in performance-based and self-reported physical functioning. J Clin Epidemiol (2005) 1.42
Current management of thyroid-associated ophthalmopathy in Europe. Results of an international survey. Clin Endocrinol (Oxf) (1998) 1.41
[Hyperthyroidism induced by iodinated roentgen contrast media]. Ned Tijdschr Geneeskd (1998) 1.40
[Increased frequency of icterus in parenterally fed patients after a change of lipid emulsion]. Ned Tijdschr Geneeskd (1999) 1.40
Ultraviolet irradiation corrects vitamin D deficiency and suppresses secondary hyperparathyroidism in the elderly. J Bone Miner Res (1998) 1.40
[Determination of cardiac troponins for diagnosis of 'acute myocardial infarct']. Ned Tijdschr Geneeskd (2001) 1.40
A new ultrasonographic method to detect disease activity and predict response to immunosuppressive treatment in Graves ophthalmopathy. Ophthalmology (1993) 1.40
Disseminated medullary thyroid carcinoma despite early thyroid surgery in the multiple endocrine neoplasia-2A syndrome. Thyroid (2005) 1.39
Orbital decompression for Graves' ophthalmopathy by inferomedial, by inferomedial plus lateral, and by coronal approach. Ophthalmology (1990) 1.39
[A case of fraud in a neurological pharmaceutical clinical trial]. Ned Tijdschr Geneeskd (2003) 1.38
[Early exclusion of ischemic myocardial damage made possible by new biochemical cardiac markers]. Ned Tijdschr Geneeskd (1998) 1.38
Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL. Br J Ophthalmol (1998) 1.38
Use of sodium hydroxide solution to clear partially occluded vascular access ports. JPEN J Parenter Enteral Nutr (1993) 1.37
Cushing's syndrome complicated by multiple opportunistic infections. J Endocrinol Invest (1998) 1.35
TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients. Clin Endocrinol (Oxf) (2003) 1.33
Vitamin D and gestational diabetes: a systematic review and meta-analysis. Eur J Intern Med (2012) 1.33
Neurologic development of the newborn and young child in relation to maternal thyroid function. Acta Paediatr (2000) 1.33
Acceptance and compliance with external hip protectors: a systematic review of the literature. Osteoporos Int (2002) 1.32
Quality of life in patients with Graves' ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid (1997) 1.31
Is there a need to redefine the upper normal limit of TSH? Eur J Endocrinol (2006) 1.30
Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments. Clin Endocrinol (Oxf) (2001) 1.30
Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol (1991) 1.29
Effects of interferon-alpha (IFN-alpha) administration on leucocytes in healthy humans. Clin Exp Immunol (1997) 1.28
Histomorphometric profile and vitamin D status in patients with femoral neck fracture. Metab Bone Dis Relat Res (1982) 1.27
Prevalence of vitamin D deficiency among Turkish, Moroccan, Indian and sub-Sahara African populations in Europe and their countries of origin: an overview. Osteoporos Int (2010) 1.26
Addressing the musculoskeletal components of fracture risk with calcium and vitamin D: a review of the evidence. Calcif Tissue Int (2006) 1.24
Vitamin D deficiency as a risk factor for osteoporotic fractures. Bone (2007) 1.24
Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goitre. Lancet (1990) 1.23
What does quality of life mean to older frail and non-frail community-dwelling adults in the Netherlands? Qual Life Res (2006) 1.20
Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol (2006) 1.19
Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab (1990) 1.19
Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult Scler (2008) 1.19
Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women. J Bone Miner Res (1995) 1.18
Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age. J Clin Endocrinol Metab (1991) 1.18
Perimenopausal bone mass and risk factors. Bone Miner (1989) 1.18
Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia. Diabetologia (2011) 1.17
Determinants of bone mineral density in older men and women: body composition as mediator. J Bone Miner Res (2001) 1.16
Extraocular muscle surgery for Graves' ophthalmopathy: does prior treatment influence surgical outcome? Br J Ophthalmol (1990) 1.15
Osteocyte density changes in aging and osteoporosis. Bone (1996) 1.14
Administration of prednisolone in vivo affects the ratio of OKT4/OKT8 and the LDH-isoenzyme pattern of human T lymphocytes. Clin Immunol Immunopathol (1984) 1.13
Magnesium levels in critically ill patients. What should we measure? Am J Clin Pathol (2000) 1.11
Prevention and treatment of vitamin D deficiency in Dutch psychogeriatric nursing home residents by weekly half-body UVB exposure after showering: a pilot study. Age Ageing (2010) 1.11